CHARLOTTETOWN, Prince Edward Island and SKOPJE, North Macedonia , July 10, 2024
(GLOBE NEWSWIRE) -- Advanced Extraction Systems Inc ("AESI") and Pharmarolly
Holdings B.V. ("Pharmarolly") are excited to announce that Pharmarolly has
successfully passed the stringent euGMP audit and obtained full euGMP
certification for their pharmaceutical facility. This achievement underscores
both companies' unwavering dedication to meeting the highest European standards
for pharmaceutical manufacturing.
This certification reflects Pharmarolly's adherence to the stringent regulations
established by the European Medicines Agency (EMA). It ensures that their
facility and processes are maintained at the highest levels of quality and
safety, reinforcing Pharmarolly's position as an industry leader.
"Achieving euGMP certification is a testament to our team's hard work and
dedication to quality," said Steve Malloy, CEO of Pharmarolly. "We have set
ourselves a high bar, and meeting the rigorous requirements of the euGMP audit
demonstrates our steadfast commitment to delivering pharmaceutical products that
meet the highest standards. This milestone is a significant step in our journey,
and we're excited about the opportunities it brings."
Peter Toombs, CEO of AESI, added, "We are thrilled to see Pharmarolly achieve
this important milestone. Their dedication to excellence and strict adherence to
euGMP guidelines have been evident throughout this process. AESI has long been a
leader in the natural products space, including the cannabis industry, and we
continue to see significant success through our partnerships and projects. We
are honored to have been part of Pharmarolly's journey and look forward to
continuing our partnership as they expand their reach in the pharmaceutical
industry."
This achievement not only validates the quality of Pharmarolly's operations but
also highlights their strong partnership with AESI, whose technology and
expertise have supported the company's efforts to achieve and maintain the
highest standards in pharmaceutical manufacturing.
About AESI
AESI designs and manufactures state-of-the-art euGMP compliant extraction
equipment for the natural products sectors worldwide. AESI's cleantech-focused
solutions enable the valorization of natural resources in a wide range of
applications worldwide.
About Pharmarolly
Pharmarolly, a Dutch company, operates a licensed cultivation subsidiary in
North Macedonia for over six years. The facility meets the highest quality
standards and holds GACP certification. The post-harvest processing area
complies with euGMP standards. Pharmarolly's executive management and entire
team is highly committed to building and maintaining a Quality Culture whereby
every decision in the company is based on what is best for product quality and
consumer safety.
Contact
Michael MacDonald
michael@AESI.co (mailto:michael@AESI.co)
(mailto:michael@AESI.co)+1-877-396-8801
Â